A detailed history of Coston, Mc Isaac & Partners transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 1,841 shares of BMY stock, worth $106,336. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,841
Previous 1,841 -0.0%
Holding current value
$106,336
Previous $76,000 25.0%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

BUY
$48.48 - $57.85 $1,066 - $1,272
22 Added 1.21%
1,841 $94,000
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $1,389 - $1,553
-24 Reduced 1.3%
1,819 $105,000
Q3 2022

Oct 31, 2022

SELL
$0.13 - $76.84 $0 - $76
-1 Reduced 0.05%
1,843 $131,000
Q2 2022

Sep 21, 2022

BUY
$72.62 - $79.98 $133,911 - $147,483
1,844 New
1,844 $142,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Coston, Mc Isaac & Partners Portfolio

Follow Coston, Mc Isaac & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coston, Mc Isaac & Partners, based on Form 13F filings with the SEC.

News

Stay updated on Coston, Mc Isaac & Partners with notifications on news.